Elite Athletes Diagnosed and Treated for Diabetes May Reduce Heart Failure

Published Date: 08 Mar 2023

95% of athletes are diagnosed and treated for non-invasive heart disease, such as heart attacks or seizures, or implantable cardioverter defibrillator (ICD) shock.

Read Full News

Latest News

CVD, ICU Stay Tied to Klebsiella Infection Post-Transplant

Klebsiella infections are common among solid organ transplant recipients older than 50; a history of cardiovascular disease and posttransplant ICU stay of 3 or more days may each raise this risk.

Two Global Forces Are Colliding in Europe’s Waiting Rooms

From sickle cell crises to kidney injury, changing patient profiles and rising temperatures are creating new clinical blind spots.

Pancreatitis Recurrence Risk Lower With GLP-1 Continuation

Contrary to regulatory warnings, research shows no link between the continuation of GLP-1s following acute pancreatitis and an increased risk for recurrence.

Med Op-Ed: Trusty Nurses, Hawthorne Effect on BP, and More

Why nurse scientists could play a key role in public health messaging, how to make sense of noisy blood pressure readings, and how much time doctors spend on mandatory training modules.

Heart Failure Hospitalizations Rose in Younger Patients

The rates of hospitalizations for heart failure rise among patients younger than 65 years and decrease in those aged 65 years or older between 2010 and 2022, a new study finds.

Scientists Rethink How Much Lifespan Is in Our Control

Research upending long-held estimates of genetic influence on lifespan could relieve the pressure to get all the lifestyle factors right.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

Klebsiella infections are common among solid organ transplant recipients older than 50; a history of cardiovascular disease and posttransplant ICU stay of 3 or more days may each raise this risk.

From sickle cell crises to kidney injury, changing patient profiles and rising temperatures are creating new clinical blind spots.

Contrary to regulatory warnings, research shows no link between the continuation of GLP-1s following acute pancreatitis and an increased risk for recurrence.

Why nurse scientists could play a key role in public health messaging, how to make sense of noisy blood pressure readings, and how much time doctors spend on mandatory training modules.

The rates of hospitalizations for heart failure rise among patients younger than 65 years and decrease in those aged 65 years or older between 2010 and 2022, a new study finds.

Research upending long-held estimates of genetic influence on lifespan could relieve the pressure to get all the lifestyle factors right.

News All Time

Statin Use Varies in Those With More CVD Risk Factors

Risk-enhancing factors are highly prevalent in adults without atherosclerotic cardiovascular disease and strongly linked to statin use in those at high risk for the condition.

Methamphetamine Use May Be a Common Cause of MI

A study from a single medical center in California has observed a nearly 15% prevalence of methamphetamine use in patients presenting with acute coronary syndrome.

Lifestyle Habits Can Amplify GLP-1 Heart Protection in T2D

Among US veterans with T2D, a combination of GLP-1 drugs and adherence to healthy lifestyle habits is associated with a greater reduction in cardiovascular risk than either approach alone.

How to Talk to Your Patients About Resistance Exercise

The American College of Sports Medicine released new guidelines this year to help doctors prescribe resistance exercise. Here’s a good way to start.

Prediabetes Tied to Weight Regain After Bariatric Surgery

Prediabetes may leave an enduring molecular ‘footprint’ on fat tissue that makes maintaining weight loss after bariatric surgery more difficult.

Diet‑Modulated Gut Microbes Predict BMI and Risk

The ZOE Microbiome Health Ranking compresses gut composition into a clinically usable indicator that correlates with BMI and disease risk and responds measurably to personalized dietary therapy.

Sirolimus-Eluting Balloon Shows Promise in ACS

Relative to routine stenting, drug-eluting balloon revascularization with as-needed stenting produced similarly low target lesion failure rates in patients with NSTEMI at 1 year.

Adrenal Causes Underlie Up to Half of Resistant Hypertension

Hypercortisolism is at least as common as hyperaldosteronism, and some people with resistant hypertension have both.

Low BMI Linked to Higher Mortality in Older Adults With T2D

Diabetes management often emphasizes the importance of weight loss, but this study suggests that thinner isn’t always better when it comes to older adults.

GLP-1 Overdoses on the Rise: Cause for Concern?

GLP-1 overdoses are on the rise, and some clinicians suggest informing patients of the risk in the initial consultation.

How Oculomics Is Bringing Systemic Disease Into Focus

Oculomics, the study of eye biomarkers of systemic disease, is gaining traction as retinal imaging and AI advance. Tear testing could take the field in a new direction.

High Lp(a) Identifies Residual Cardiovascular Risk

Elevated lipoprotein(a) increases risk, especially in those with existing cardiovascular disease.

When Protecting Patients Conflicts With Telling the Truth

Physicians describe when delayed disclosure may be justified and why lying to patients is never ethically acceptable, even under family pressure.

GLP-1 RA Use May Improve Outcomes in HFrEF

In patients who have heart failure with reduced ejection fraction, GLP-1 receptor agonist use is associated with a lower risk for mortality and acute decompensated heart failure.

Two Hair Loss Drugs Not Tied to Heart Disease Risk

Oral 5-alpha-reductase inhibitors do not increase the risk for cardiovascular disease in patients treated for androgenetic alopecia, study finds.

Early MCS May Improve Survival in Severe Cardiogenic Shock

Patients with severe cardiogenic shock benefit from early escalation to mechanical circulatory support, according to a recent study.

Recommended News For You

Prior authorizations draining time, energy from many cancer patients

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Regular physical activity before cancer diagnosis may lower progression and death risks

combating racial discrimination in next-generation breast cancer screening.

A new theranostic drug targets different cancer types.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Recommended Articles For You

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unmasking the Subtle Symptoms of Colon Cancer 

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Taking Charge of Your Cancer Journey.

5.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

1.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

2.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

3.

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy

4.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

5.

Cemiplimab: A Revolutionary Drug For Treating Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot